Cytological changes in the cervix, vagina and vulva

Current Care Summary
Working group set up by the Finnish Medical Society Duodecim and the Finnish Colposcopy Association

Cervical cancer screening guidelines

Annually approximately 160 new cervical cancers are diagnosed in Finland. Screening has decreased both incidence and mortality by 80%. Both primary HPV-testing and Pap smear can be used in screening. In the future HPV vaccination will decrease the number of cervical cancers. Abnormal findings in Pap smears indicate management. LSIL lesions are followed up especially among young women and HSIL lesions treated. Follow-up after treatment should be reliably arranged, because increased risk of cancer remains even after treatment.

Pekka Nieminen (Chair)

Ahti Anttila

Ralf Bützow

Eija Hiltunen-Back

Maija Jakobsson

Tanja Laukkala

Johanna Mäenpää

Johanna Palmroth

Virpi Rantanen

Marjut Rintala

Annika Riska

Anne Santalahti

Marja Simojoki

Maarit Vuento

Piia Vuorela